Regarding the intensity of Siglec-15 expression in tumor cells, 28 cases (47.5%) were mildly positive (IRS 1–3), 26 cases (44.8%) were moderately positive (IRS 4–8), and 4 cases (6.9%) were strongly positive (IRS 9–12). The gene discussed is IARS1; the disease is neoplasm.